Mechanism of amphotericin B resistance in clinical isolates of Leishmania donovani - Wikidata - awgldk - TriplyDB

Mechanism of amphotericin B resistance in clinical isolates of Leishmania donovani

Mechanism of amphotericin B resistance in clinical isolates of Leishmania donovani

http://www.wikidata.org/entity/Q39436217

about

Eugenia uniflora L. Essential Oil as a Potential Anti-Leishmania Agent: Effects on Leishmania amazonensis and Possible Mechanisms of Action Comparative analysis of the omics technologies used to study antimonial, amphotericin B, and pentamidine resistance in leishmania New Approaches to Overcome Transport Related Drug Resistance in Trypanosomatid Parasites Current challenges in treatment options for visceral leishmaniasis in India: a public health perspective Drug resistance in natural isolates of Leishmania donovani s.l. promastigotes is dependent of Pgp170 expression Stage-dependent expression and up-regulation of trypanothione synthetase in amphotericin B resistant Leishmania donovani Allopurinol Resistance in Leishmania infantum from Dogs with Disease Relapse Different Mutations in a P-type ATPase Transporter in Leishmania Parasites are Associated with Cross-resistance to Two Leading Drugs by Distinct Mechanisms In vitro anti-Leishmania activity of tetracyclic iridoids from Morinda lucida, benth Antimony transport mechanisms in resistant leishmania parasites.Combined treatment of miltefosine and paromomycin delays the onset of experimental drug resistance in Leishmania infantum.Intracellular zinc flux causes reactive oxygen species mediated mitochondrial dysfunction leading to cell death in Leishmania donovani.Visceral leishmaniasis and HIV co-infection in Bihar, India: long-term effectiveness and treatment outcomes with liposomal amphotericin B (AmBisome)Host-mediated Leishmania donovani treatment using AR-12 encapsulated in acetalated dextran microparticles.Deprivation of L-Arginine Induces Oxidative Stress Mediated Apoptosis in Leishmania donovani Promastigotes: Contribution of the Polyamine Pathway Combination Treatment for Visceral Leishmaniasis Patients Coinfected with Human Immunodeficiency Virus in India Novel Agents against Miltefosine-Unresponsive Leishmania donovani.Sterol 14α-demethylase mutation leads to amphotericin B resistance in Leishmania mexicana.Liposomal amphotericin B as a treatment for human leishmaniasis Universal minicircle sequence binding protein of Leishmania donovani regulates pathogenicity by controlling expression of cytochrome-b.Activity of a novel sulfonamide compound 2-nitro-N-(pyridin-2-ylmethyl)benzenesulfonamide against Leishmania donovani.Association Between ABCB1 (MDR1) Gene Polymorphism and Unresponsiveness Combined Therapy in Chronic Hepatitis C virus Cos-Seq for high-throughput identification of drug target and resistance mechanisms in the protozoan parasite Leishmania.Genomic Appraisal of the Multifactorial Basis for In Vitro Acquisition of Miltefosine Resistance in Leishmania donovani The Role of Signaling via Aqueous Pore Formation in Resistance Responses to Amphotericin B Liposomal resiquimod for the treatment of Leishmania donovani infection.Therapeutic effect of ursolic acid in experimental visceral leishmaniasis Phosphorylation of Translation Initiation Factor 2-Alpha in Leishmania donovani under Stress Is Necessary for Parasite Survival.In vitro synergistic effect of amphotericin B and allicin on Leishmania donovani and L. infantum.Identification and Characterization of miRNAs in Response to Leishmania donovani Infection: Delineation of Their Roles in Macrophage Dysfunction Deciphering the interplay between cysteine synthase and thiol cascade proteins in modulating Amphotericin B resistance and survival of Leishmania donovani under oxidative stress.Drug resistance in leishmaniasis: Newer developments.Elucidation of cellular mechanisms involved in experimental paromomycin resistance in Leishmania donovani.Combination therapy with tamoxifen and amphotericin B in experimental cutaneous leishmaniasis.Modes of action of Leishmanicidal antimicrobial peptides.Vaccine potential of HLA-A2 epitopes from Leishmania Cysteine Protease Type III (CPC).Development of mannose-anchored thiolated amphotericin B nanocarriers for treatment of visceral leishmaniasis.Host resistance to visceral leishmaniasis: prevalence and prevention.Specific noninvasive detection of Leishmania donovani in desquamated buccal cell swab samples from human visceral Leishmaniasis-HIV coinfected patients.Experimental resistance to drug combinations in Leishmania donovani: metabolic and phenotypic adaptations.

P2860

Q21285094-202C5C53-1B5D-41A9-B0EF-A04C649F3190 Q27009505-C3DE870F-A3A0-45E7-8715-CD7BB1175DA4 Q28068159-0CD661C4-55C4-40FF-A22A-5D98724B4EC4 Q28073426-B1F9E72F-604A-44B8-A2ED-6A51932F712D Q28533820-C7238EA6-2E4D-4063-8880-B831B8ED4072 Q28539382-2E6E56FF-5346-41E9-AB26-39538C4B7C1B Q28552396-B67CA07B-A6BC-4271-8866-908BCE01B192 Q28554770-C04D6C4D-792E-4D26-82BE-0F883F734DF2 Q28831274-13685472-13CB-419C-8872-A5E67B1489C1 Q33659312-A0AC8339-8D06-4B95-83D3-EB9F200C0367 Q33728704-B329570C-38D8-486E-A937-D761787F3070 Q33769084-DDE87BE7-6527-483A-8DA8-18D7396F434A Q34016144-F3994B19-245F-4803-8FA6-323F8F29BCD1 Q34509079-74E8F7C1-8A97-49F8-935A-18E334C92614 Q35903818-35AD6AB1-863F-4DFC-80C0-0276FE640116 Q36094248-2A38F2BD-91C9-4963-A7BD-07BC476607C8 Q36290836-9BECFDE7-DC90-4EF2-BB71-30026CC646B8 Q36407342-845D10EF-F3C5-4EE2-BF4E-D10694320A04 Q36456032-1BC3B3FE-4D00-432E-A975-98D509293083 Q36588170-CE9CBCDE-4847-4E12-B9FC-78097F0C70AC Q36951476-2485B779-8F40-4ABF-BBF5-C90C3205DC2B Q36957096-259145DC-DD9C-485E-862E-5DD47F3411BD Q36957213-41FFEC3F-2483-4E95-AFF9-61EB01D4E16E Q37023262-6065EAA1-5341-4274-A682-4E7492545C45 Q37203821-B16364BF-4019-4436-90C0-852C4EDF2670 Q37388288-FC7A0DDA-3B25-480B-8C7E-63DC72CF07A9 Q37503612-B5AD1D2D-35B8-4374-A804-64C01B52E1A8 Q37538574-0AB69E42-D231-4EBD-8B1F-6CBC6E2B6627 Q37643719-51EBD431-78FD-465B-93A9-B1EA3228725F Q37675397-3CC67D40-DA87-4A7C-A3B4-E63E9656E826 Q37698643-081F845F-FF4B-4831-A72F-1E054E99F050 Q37712190-EF676D70-CF96-4D44-B798-D82679D50C25 Q37712969-B6CF8104-FF90-46AA-BF37-62226E676674 Q37712995-8E281C11-7E98-4AC2-AAB2-64153F9BC504 Q38041188-7B8984B4-1F60-4681-94E7-9979294BB623 Q38700268-CEAA4F2F-3021-4865-8393-30F596E506AF Q38729357-AC3907E8-B2E3-4ED2-80BB-8ABD4D7A88AD Q38757973-60560BAF-B5A3-4F51-A146-1529AF62A101 Q38853910-C666C4A0-A839-473F-A747-99B6BB469BAC Q38904942-4D860373-9AE4-47A8-8A13-740A80CF6537

P2860

Mechanism of amphotericin B resistance in clinical isolates of Leishmania donovani

http://www.wikidata.org/entity/Q39436217

description

2011 nî lūn-bûn

@nan

2011年の論文

@ja

2011年学术文章

@wuu

2011年学术文章

@zh-cn

2011年学术文章

@zh-hans

2011年学术文章

@zh-my

2011年学术文章

@zh-sg

2011年學術文章

@yue

2011年學術文章

@zh

2011年學術文章

@zh-hant

name

Mechanism of amphotericin B resistance in clinical isolates of Leishmania donovani

@en

Mechanism of amphotericin B resistance in clinical isolates of Leishmania donovani.

@nl

type

label

Mechanism of amphotericin B resistance in clinical isolates of Leishmania donovani

@en

Mechanism of amphotericin B resistance in clinical isolates of Leishmania donovani.

@nl

prefLabel

Mechanism of amphotericin B resistance in clinical isolates of Leishmania donovani

@en

Mechanism of amphotericin B resistance in clinical isolates of Leishmania donovani.

@nl

P1433

Q39436217-7CAF4ACE-66A5-44E6-B0AB-A1563414CB47

P1476

Q39436217-7DD2DB1E-FAB8-4266-878A-497B03A29C1E

P2093

Q39436217-17F58441-B780-4F4F-9238-3A35802672AA

Q39436217-1F47BCDE-EA1E-4193-BC06-F7A9DABBC9BF

Q39436217-3400DC85-B5A0-4A66-BA4F-2282AE35F722

Q39436217-6EE1AF5E-E836-43B3-8E56-EC59286D6BEE

Q39436217-7F5956A8-C0B2-4F3F-9A69-02E8CF34EB5D

Q39436217-8E9B1BC4-66A5-4545-A82D-AC4648C4C334

Q39436217-B58F9D8B-4CF1-46DD-8EF2-D4CA323494EA

Q39436217-BBD86158-AFB8-48C0-83A0-4454BC7BD1D7

Q39436217-E521B6D9-D605-4907-9442-81FC27948354

Q39436217-EA223FB1-CF24-46D2-B4B3-FF3D4D4B1A71

P2860

Q39436217-012705BA-C2F6-4C9E-97AA-29B4355D4249

Q39436217-03CECBEF-30CC-4393-A783-4D444DB9AD45

Q39436217-0581AB13-6862-43DD-9E25-AFF66CF0A0CF

Q39436217-07D47B8B-6BDA-4E48-AC7C-65AC3738F2E0

Q39436217-0961E7A9-E4C1-4AC5-8B86-10BF0E72862A

Q39436217-0A213172-C398-4EFA-9870-39C7223F9E27

Q39436217-0EE2B4F8-1904-4374-BE49-64EC22D915B9

Q39436217-1104A574-5A0F-4D0A-939F-FF25F1269151

Q39436217-2E6A170B-7463-4DA8-8743-857AD58195DD

Q39436217-371A5C15-2CF9-4BF5-B902-925C8CD5F855

P304

Q39436217-BEC19B73-734A-419C-A3A3-85841E9BEDFA

P31

Q39436217-45F089DE-8CB3-45A4-AA62-AB1C8B984C58

P356

Q39436217-67679403-DB78-44C0-A718-5BA7357D935B

P407

Q39436217-C72CB090-7C41-4785-8AD5-0E37C261AA57

P433

Q39436217-77CE5846-697D-4955-9AC9-15F6F61E0048

P478

Q39436217-036F6EDB-37E6-4897-92F3-792F9687058D

P577

Q39436217-4657F980-F1BB-42F2-B566-915F7595DEE8

P5875

Q39436217-8A5B72B7-5472-46A7-90A7-159A8EAC6867

P698

Q39436217-AE8A56C0-4328-4AB2-B2C9-EBD55888D641

P932

Q39436217-FC0D275D-DDB8-47F1-A94D-68D7EE43B42B

P356

P1433

Antimicrobial Agents and Chemotherapy

P1476

Mechanism of amphotericin B resistance in clinical isolates of Leishmania donovani

@en

P2093

Abul Hasan Sardar

http://www.w3.org/2001/XMLSchema#string

Ashish Kumar

http://www.w3.org/2001/XMLSchema#string

Bidyut Purkait

http://www.w3.org/2001/XMLSchema#string

Dharmendra Singh

http://www.w3.org/2001/XMLSchema#string

Krishna Pandey

http://www.w3.org/2001/XMLSchema#string

Manish Kumar

http://www.w3.org/2001/XMLSchema#string

Nilay Nandi

http://www.w3.org/2001/XMLSchema#string

Pradeep Das

http://www.w3.org/2001/XMLSchema#string

Sudeep Kumar

http://www.w3.org/2001/XMLSchema#string

Sushmita Das

http://www.w3.org/2001/XMLSchema#string

P2860

Trypanothione overproduction and resistance to antimonials and arsenicals in Leishmania

Tissue sulfhydryl groups

ABC transporters: from microorganisms to man

Trypanothione: a novel bis(glutathionyl)spermidine cofactor for glutathione reductase in trypanosomatids

Drug resistance in leishmaniasis

Multidrug resistance in Leishmania donovani is conferred by amplification of a gene homologous to the mammalian mdr1 gene

Mechanism of amphotericin B resistance in Leishmania donovani promastigotes.

Glutathione and trypanothione in parasitic hydroperoxide metabolism.

Metabolism and functions of trypanothione in the Kinetoplastida.

Sterol structure and membrane function.

P304

1031-1041

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1128/AAC.00030-11

http://www.w3.org/2001/XMLSchema#string

P407

P433

2

http://www.w3.org/2001/XMLSchema#string

P478

56

http://www.w3.org/2001/XMLSchema#string

P577

2011-11-28T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

51832863

http://www.w3.org/2001/XMLSchema#string

P698

22123699

http://www.w3.org/2001/XMLSchema#string

P932

3264217

http://www.w3.org/2001/XMLSchema#string